TAIM
RMD icon

TD Ameritrade Investment Management’s ResMed RMD Stock Holding History

TD Ameritrade Investment Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10
Closed -$1K – 708
2019
Q2 		$1K Buy
+10
New +$1.11K ﹤0.01% 623

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

TD Ameritrade Investment Management's RMD Position: Q3 2019 in Review

TD Ameritrade Investment Management sold out of ResMed (RMD) in Q3 2019, closing a stake of 10 shares — an estimated $1K sold.

TD Ameritrade Investment Management first reported a position in RMD in Q2 2019 and held it in 1 quarter. The position peaked at $1K in Q2 2019. 527 funds tracked by Wall St. Rank hold RMD as of Q3 2019.

  • TD Ameritrade Investment Management reported no remaining ResMed position as of Q3 2019 after selling out during the quarter.
  • TD Ameritrade Investment Management sold 10 ResMed shares in Q3 2019, an estimated $1K.
  • TD Ameritrade Investment Management first reported a position in ResMed in Q2 2019 and held it in 1 quarter.
  • TD Ameritrade Investment Management's ResMed position peaked at $1K in Q2 2019.
  • 527 funds tracked by Wall St. Rank held ResMed as of Q3 2019.

Based on TD Ameritrade Investment Management's 13F filing for Q3 2019, filed 7 Nov 2019.